MEDIAN TECHNOLOGIES (ALMDT.PA) Fundamental Analysis & Valuation

EPA:ALMDT • FR0011049824

5.07 EUR
+0.07 (+1.4%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ALMDT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALMDT. ALMDT was compared to 11 industry peers in the Health Care Technology industry. Both the profitability and financial health of ALMDT have multiple concerns. While showing a medium growth rate, ALMDT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. ALMDT.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALMDT has reported negative net income.
  • ALMDT had a negative operating cash flow in the past year.
  • In the past 5 years ALMDT always reported negative net income.
  • In the past 5 years ALMDT always reported negative operating cash flow.
ALMDT.PA Yearly Net Income VS EBIT VS OCF VS FCFALMDT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

  • ALMDT has a Return On Assets of -113.84%. This is amonst the worse of the industry: ALMDT underperforms 81.82% of its industry peers.
Industry RankSector Rank
ROA -113.84%
ROE N/A
ROIC N/A
ROA(3y)-75.23%
ROA(5y)-63.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMDT.PA Yearly ROA, ROE, ROICALMDT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

  • ALMDT has a better Gross Margin (102.73%) than 100.00% of its industry peers.
  • ALMDT's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALMDT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 102.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.46%
GM growth 5Y0.99%
ALMDT.PA Yearly Profit, Operating, Gross MarginsALMDT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. ALMDT.PA Health Analysis

2.1 Basic Checks

  • ALMDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALMDT has more shares outstanding than it did 1 year ago.
  • ALMDT has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALMDT has a worse debt to assets ratio.
ALMDT.PA Yearly Shares OutstandingALMDT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ALMDT.PA Yearly Total Debt VS Total AssetsALMDT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • ALMDT has an Altman-Z score of -11.88. This is a bad value and indicates that ALMDT is not financially healthy and even has some risk of bankruptcy.
  • ALMDT has a worse Altman-Z score (-11.88) than 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -11.88
ROIC/WACCN/A
WACC7.67%
ALMDT.PA Yearly LT Debt VS Equity VS FCFALMDT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • A Current Ratio of 0.35 indicates that ALMDT may have some problems paying its short term obligations.
  • ALMDT has a worse Current ratio (0.35) than 81.82% of its industry peers.
  • A Quick Ratio of 0.35 indicates that ALMDT may have some problems paying its short term obligations.
  • The Quick ratio of ALMDT (0.35) is worse than 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
ALMDT.PA Yearly Current Assets VS Current LiabilitesALMDT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ALMDT.PA Growth Analysis

3.1 Past

  • ALMDT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.99%, which is quite good.
  • The Revenue has been growing slightly by 6.75% in the past year.
  • Measured over the past years, ALMDT shows a very strong growth in Revenue. The Revenue has been growing by 20.72% on average per year.
EPS 1Y (TTM)9.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y3.75%
Revenue growth 5Y20.72%
Sales Q2Q%3.3%

3.2 Future

  • Based on estimates for the next years, ALMDT will show a very strong growth in Earnings Per Share. The EPS will grow by 26.15% on average per year.
  • Based on estimates for the next years, ALMDT will show a very strong growth in Revenue. The Revenue will grow by 22.71% on average per year.
EPS Next Y33.59%
EPS Next 2Y30.92%
EPS Next 3Y26.15%
EPS Next 5YN/A
Revenue Next Year3.31%
Revenue Next 2Y17.55%
Revenue Next 3Y22.71%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALMDT.PA Yearly Revenue VS EstimatesALMDT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
ALMDT.PA Yearly EPS VS EstimatesALMDT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALMDT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALMDT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALMDT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMDT.PA Price Earnings VS Forward Price EarningsALMDT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMDT.PA Per share dataALMDT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALMDT's earnings are expected to grow with 26.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.92%
EPS Next 3Y26.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALMDT.PA Dividend Analysis

5.1 Amount

  • No dividends for ALMDT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALMDT.PA Fundamentals: All Metrics, Ratios and Statistics

MEDIAN TECHNOLOGIES

EPA:ALMDT (3/3/2026, 7:00:00 PM)

5.07

+0.07 (+1.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)10-23
Earnings (Next)04-23
Inst Owners10.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap186.17M
Revenue(TTM)23.31M
Net Income(TTM)-22.21M
Analysts85.45
Price Target8.81 (73.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-24.4%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.99
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS0.63
BVpS-1.1
TBVpS-1.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -113.84%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 102.73%
FCFM N/A
ROA(3y)-75.23%
ROA(5y)-63.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.46%
GM growth 5Y0.99%
F-Score2
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.46%
Cap/Sales 3.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z -11.88
F-Score2
WACC7.67%
ROIC/WACCN/A
Cap/Depr(3y)102.16%
Cap/Depr(5y)84.24%
Cap/Sales(3y)5.46%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y33.59%
EPS Next 2Y30.92%
EPS Next 3Y26.15%
EPS Next 5YN/A
Revenue 1Y (TTM)6.75%
Revenue growth 3Y3.75%
Revenue growth 5Y20.72%
Sales Q2Q%3.3%
Revenue Next Year3.31%
Revenue Next 2Y17.55%
Revenue Next 3Y22.71%
Revenue Next 5YN/A
EBIT growth 1Y26.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.89%
EBIT Next 3Y19.25%
EBIT Next 5YN/A
FCF growth 1Y23.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.85%
OCF growth 3YN/A
OCF growth 5YN/A

MEDIAN TECHNOLOGIES / ALMDT.PA FAQ

What is the ChartMill fundamental rating of MEDIAN TECHNOLOGIES (ALMDT.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALMDT.PA.


What is the valuation status for ALMDT stock?

ChartMill assigns a valuation rating of 1 / 10 to MEDIAN TECHNOLOGIES (ALMDT.PA). This can be considered as Overvalued.


What is the profitability of ALMDT stock?

MEDIAN TECHNOLOGIES (ALMDT.PA) has a profitability rating of 1 / 10.


How financially healthy is MEDIAN TECHNOLOGIES?

The financial health rating of MEDIAN TECHNOLOGIES (ALMDT.PA) is 0 / 10.